Sonazoid动态对比增强超声预测早期肝细胞癌微血管侵犯
这项单中心前瞻性研究纳入140例经组织病理学证实的单发肝细胞癌患者,术前1周内行Sonazoid动态对比增强超声定量灌注分析。MVI+组32例与MVI-组108例相比,病灶半衰减时间、廓清率及病灶边缘与远端肝实质动脉期峰值增强差值有显著差异;联合上述三项参数预测MVI的准确率69.3%(97/140)、敏感度37.8%(17/45)、特异度84.3%(80/95)、阳性预测值53.1%(17/32)、阴性预测值74.1%(80/108)。作者认为Sonazoid动态对比增强超声定量灌注分析有潜力术前预测肝细胞癌微血管侵犯。
要点
- Sonazoid动态对比增强超声定量灌注参数在MVI+与MVI-组间有差异。
- 联合三项定量参数预测MVI准确率69.3%(97/140)、特异度84.3%(80/95)。
- 联合三项定量参数预测MVI敏感度37.8%(17/45)、阴性预测值74.1%(80/108)。
核心结论
- Sonazoid动态对比增强超声定量灌注分析有潜力术前预测肝细胞癌病灶的微血管侵犯。
研究设计与样本
- 单中心前瞻性研究,纳入140例经组织病理学证实的单发肝细胞癌病灶患者,术前1周内行Sonazoid动态对比增强超声检查。
关键影像表现/征象
- MVI+组与MVI-组在血清甲胎蛋白、脱γ羧基凝血酶原及病理分级等临床病理特征上差异有统计学意义(p<0.05)。
- MVI+组与MVI-组在肿瘤大小这一灰阶影像特征上差异有统计学意义(p<0.05)。
- MVI+组与MVI-组相比,病灶半衰减时间差异有统计学意义(p=0.045)。
- MVI+组与MVI-组相比,病灶廓清率差异有统计学意义(p=0.035)。
- MVI+组与MVI-组相比,病灶边缘与远端肝实质动脉期峰值增强差值差异有统计学意义(p=0.023)。
诊断标准与关键数值
- 联合半衰减时间、廓清率及病灶边缘与远端肝实质动脉期峰值增强差值三项定量参数预测MVI:准确率69.3%(97/140)、敏感度37.8%(17/45)、特异度84.3%(80/95)、阳性预测值53.1%(17/32)、阴性预测值74.1%(80/108)。
- MVI分组依据为术后病理信息:MVI+组32例,MVI-组108例。
临床应用与阅片要点
- 作者认为Sonazoid动态对比增强超声定量灌注分析有潜力术前预测肝细胞癌微血管侵犯。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: Microvascular invasion (MVI) is an independent risk factor for the early recurrence and poor survival of hepatocellular carcinoma (HCC). This study aims to investigate the potential clinical value of dynamic contrast-enhanced ultrasound (DCE-ultrasound)-Sonazoid in pre-operatively assessing MVI in HCC.
METHODS AND MATERIALS: This single centre prospective study included 140 patients with histopathologically confirmed single HCC lesions. Patients were classified according to the post-operative pathological information presence of MVI: MVI+ group (n = 32) and MVI- group (n = 108). All patients underwent DCE-ultrasound within 1 week before surgery. The quantitative perfusion parameters of HCC lesions, margins of HCC lesions, and distal liver parenchyma were obtained and analyzed.
RESULTS: Clinicopathological (serum alpha-fetoprotein, Des-gamma-carboxyprothrombin, and pathological grade) and grayscale imaging features (tumor size) were significantly different between the MVI+ and MVI- groups (p < 0.05). Further quantitative analysis showed that when comparing the MVI+ and MVI- groups, half-decrease time and wash-out rate of HCC lesions and peak enhancement in the arterial phase of difference between the margin area of HCC and distal liver parenchyma were significantly different (p = 0.045, p = 0.035, and p = 0.023, respectively). Combining the above three quantitative parameters, the accuracy, sensitivity, specificity, positive-predictive value, and negative-predictive value were 69.3% (97/140), 37.8% (17/45), 84.3% (80/95), 53.1% (17/32), 74.1% (80/108), respectively.
CONCLUSION: DCE-ultrasound with quantitative perfusion analysis has the potential to predict MVI in HCC lesions.
ADVANCES IN KNOWLEDGE: DCE-ultrasound with quantitative perfusion analysis has the potential to predict MVI in HCC lesions.
引用
- Huang Z, Xin JY, Wu LL, et al. Dynamic contrast-enhanced ultrasonography with sonazoid predicts microvascular invasion in early-stage hepatocellular carcinoma. Br J Radiol. 2023. PMID: 37750942. doi:10.1259/bjr.20230164
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。